Dawn R. Mattoon
Vorstandsvorsitzender bei Mercy Bioanalytics, Inc.
Aktive Positionen von Dawn R. Mattoon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Mercy Bioanalytics, Inc.
Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Direktor/Vorstandsmitglied | 15.02.2023 | - |
Vorstandsvorsitzender | 15.02.2023 | - | |
Geschäftsführer | 11.07.2022 | 15.02.2023 |
Karriereverlauf von Dawn R. Mattoon
Ehemalige bekannte Positionen von Dawn R. Mattoon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
QUANTERIX CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2018 | - |
Corporate Officer/Principal | 01.02.2018 | - | |
Cell Signaling Technology, Inc.
Cell Signaling Technology, Inc. Medical SpecialtiesHealth Technology Cell Signaling Technology, Inc. manufactures and distributes research tools for cell function and diseases. It offers primary antibodies, activators and inhibitors, buffers and dyes, cellsimple, and cytokines. The company was founded in 1999 and is headquartered in Danvers, MA. | Corporate Officer/Principal | 01.07.2014 | 01.02.2018 |
Ausbildung von Dawn R. Mattoon
Yale University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
QUANTERIX CORPORATION | Health Technology |
Private Unternehmen | 2 |
---|---|
Cell Signaling Technology, Inc.
Cell Signaling Technology, Inc. Medical SpecialtiesHealth Technology Cell Signaling Technology, Inc. manufactures and distributes research tools for cell function and diseases. It offers primary antibodies, activators and inhibitors, buffers and dyes, cellsimple, and cytokines. The company was founded in 1999 and is headquartered in Danvers, MA. | Health Technology |
Mercy Bioanalytics, Inc.
Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Health Technology |
- Börse
- Insiders
- Dawn R. Mattoon
- Erfahrung